Lubner David Charles sold Arcellx Inc. ($ACLX) shares once on the open market in the last year, totaling $450,000, with the most recent sale on January 20, 2026. His sales rank 6,705th among 11,678 individual insiders, below the average of 8.6 million per seller and 6.4 transactions. He made no open market purchases of ACLX stock.
| Transaction Date | Company | Ticker | Insider Name | Title | Transaction Type | Security | Shares | Price | Shares Owned Following | Total Shares Outstanding | % of Owned | % of Outstanding |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Jan. 20, 2026 | Arcellx, Inc. | $ACLX | Lubner David Charles | Not found | M | Stock Option (right to buy) | 6000 | $0.00 | 59,405.0000 | 57,822,871 | 9.17% | 0.01% |
| Jan. 20, 2026 | Arcellx, Inc. | $ACLX | Lubner David Charles | Not found | S | Common Stock | 6000 | $75.00 | 21,659.0000 | 57,822,871 | 21.69% | 0.01% |
| Jan. 20, 2026 | Arcellx, Inc. | $ACLX | Lubner David Charles | Not found | M | Common Stock | 6000 | $6.28 | 27,659.0000 | 57,822,871 | 27.70% | 0.01% |
| Aug. 19, 2025 | CARGO Therapeutics, Inc. | $CRGX | Lubner David Charles | Not found | D | Stock Option (Right to Buy) | 25000 | $0.00 | 0.0000 | 48,364,311 | 100.00% | 0.05% |
| June 23, 2025 | CRESCENT BIOPHARMA, INC. | $CBIO | Lubner David Charles | Director | A | Stock Option (Right to Buy) | 9023 | $0.00 | 9,023.0000 | 0 | 9999.99% | 0.00% |
| June 18, 2025 | CARGO Therapeutics, Inc. | $CRGX | Lubner David Charles | Not found | A | Stock Option (Right to Buy) | 25000 | $0.00 | 25,000.0000 | 46,052,368 | 9999.99% | 0.05% |
| May 30, 2025 | Dyne Therapeutics, Inc. | $DYN | Lubner David Charles | Not found | A | Stock option (right to buy) | 35000 | $0.00 | 35,000.0000 | 113,121,357 | 9999.99% | 0.03% |
| May 29, 2025 | Arcellx, Inc. | $ACLX | Lubner David Charles | Not found | A | Stock Option (right to buy) | 9174 | $0.00 | 9,174.0000 | 54,944,012 | 9999.99% | 0.02% |
| May 22, 2025 | Vor Biopharma Inc. | $VOR | Lubner David Charles | Not found | A | Stock Option (Right to Buy) | 30000 | $0.00 | 30,000.0000 | 124,851,547 | 9999.99% | 0.02% |
| May 28, 2024 | Arcellx, Inc. | $ACLX | Lubner David Charles | Not found | A | Stock Option (right to buy) | 8011 | $0.00 | 8,011.0000 | 0 | 9999.99% | 0.00% |
| June 4, 2024 | CARGO Therapeutics, Inc. | $CRGX | Lubner David Charles | Not found | A | Stock Option (Right to Buy) | 23742 | $0.00 | 23,742.0000 | 0 | 9999.99% | 0.00% |
| May 23, 2024 | Vor Biopharma Inc. | $VOR | Lubner David Charles | Not found | A | Stock Option (Right to Buy) | 30000 | $0.00 | 30,000.0000 | 0 | 9999.99% | 0.00% |
| May 22, 2024 | Dyne Therapeutics, Inc. | $DYN | Lubner David Charles | Not found | A | Stock option (right to buy) | 25133 | $0.00 | 25,133.0000 | 0 | 9999.99% | 0.00% |
| June 14, 2023 | Arcellx, Inc. | $ACLX | Lubner David Charles | Director | A | Stock Option (right to buy) | 11459 | $0.00 | 11,459.0000 | 0 | 9999.99% | 0.00% |
| May 26, 2023 | Vor Biopharma Inc. | $VOR | Lubner David Charles | Director | A | Stock Option (right to buy) | 30000 | $0.00 | 30,000.0000 | 0 | 9999.99% | 0.00% |
| May 24, 2023 | Dyne Therapeutics, Inc. | $DYN | Lubner David Charles | Director | A | Stock Option (right to buy) | 24900 | $0.00 | 24,900.0000 | 0 | 9999.99% | 0.00% |